PROACT Xa - A Trial to Determine if Participants With an On-X Aortic Valve Can be Maintained Safely on Apixaban
Status:
Recruiting
Trial end date:
2024-07-01
Target enrollment:
Participant gender:
Summary
Currently, warfarin is the only approved anticoagulation for patients with mechanical valves.
The purpose of this study is to determine if participants with an On-X Prosthetic Heart Valve
/ On-X aortic valve can be maintained safely and effectively on apixaban. Both the On-X
aortic valve and apixaban have been approved for use by the US Food and Drug Administration
(FDA) but they have not been approved to be used together.